chr1-10365492-C-T

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_001365951.3(KIF1B):​c.4596C>T​(p.Pro1532=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00245 in 1,614,184 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0026 ( 6 hom. )

Consequence

KIF1B
NM_001365951.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 3.27
Variant links:
Genes affected
KIF1B (HGNC:16636): (kinesin family member 1B) Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in chemical synaptic transmission; dense core granule cytoskeletal transport; and vesicle-mediated transport. Predicted to act upstream of or within mitochondrion transport along microtubule. Predicted to be located in cytoplasmic vesicle membrane and neuron projection. Predicted to be part of kinesin complex. Predicted to be active in several cellular components, including axon; dendrite; and microtubule. Implicated in Charcot-Marie-Tooth disease type 2A1; carcinoma (multiple); multiple sclerosis; neuroblastoma; and pheochromocytoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 1-10365492-C-T is Benign according to our data. Variant chr1-10365492-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 215516.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-10365492-C-T is described in Lovd as [Benign]. Variant chr1-10365492-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=3.27 with no splicing effect.
BS2
High AC in GnomAd4 at 221 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KIF1BNM_001365951.3 linkuse as main transcriptc.4596C>T p.Pro1532= synonymous_variant 43/49 ENST00000676179.1 NP_001352880.1
KIF1BNM_001365952.1 linkuse as main transcriptc.4596C>T p.Pro1532= synonymous_variant 43/49 NP_001352881.1
KIF1BNM_015074.3 linkuse as main transcriptc.4458C>T p.Pro1486= synonymous_variant 41/47 NP_055889.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KIF1BENST00000676179.1 linkuse as main transcriptc.4596C>T p.Pro1532= synonymous_variant 43/49 NM_001365951.3 ENSP00000502065 P1O60333-1

Frequencies

GnomAD3 genomes
AF:
0.00145
AC:
221
AN:
152172
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00662
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00237
Gnomad OTH
AF:
0.000958
GnomAD3 exomes
AF:
0.00169
AC:
426
AN:
251470
Hom.:
1
AF XY:
0.00176
AC XY:
239
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.00883
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00111
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00233
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00255
AC:
3732
AN:
1461894
Hom.:
6
Cov.:
34
AF XY:
0.00247
AC XY:
1793
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000418
Gnomad4 AMR exome
AF:
0.000313
Gnomad4 ASJ exome
AF:
0.00937
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00141
Gnomad4 FIN exome
AF:
0.000262
Gnomad4 NFE exome
AF:
0.00288
Gnomad4 OTH exome
AF:
0.00205
GnomAD4 genome
AF:
0.00145
AC:
221
AN:
152290
Hom.:
4
Cov.:
31
AF XY:
0.00126
AC XY:
94
AN XY:
74458
show subpopulations
Gnomad4 AFR
AF:
0.000481
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00662
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.00237
Gnomad4 OTH
AF:
0.000948
Alfa
AF:
0.00248
Hom.:
0
Bravo
AF:
0.00159
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00300
EpiControl
AF:
0.00166

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 17, 2023- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024KIF1B: BP4, BP7, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:3
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 10, 2020This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 25, 2016- -
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Neuroblastoma Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Charcot-Marie-Tooth disease type 2 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 28, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
12
DANN
Benign
0.69
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147066476; hg19: chr1-10425550; API